David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?
نویسندگان
چکیده
Dept of Medicine, Division of Rheumatology, DenoThe center, University of Florence, Italy. Irene Miniati, MD, Rheumatologist; Maria Letizia Conforti, MD, Rheumatologist; Serena Guiducci, MD, Fellow in Rheumatology; Marco Matucci Cerinic, MD, Professor of Rheumatology. Please address correspondence to: Irene Miniati, Div. Rheumatology, Villa Monna Tessa, Viale Pieraccini 18 50139 Firenze, Italy. E-mail: [email protected] Received on May 2, 2007; accepted in revised form on May 4, 2007. © Copyright CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2007.
منابع مشابه
درگیری پارانشیم ریه در بیماران سیستمیک اسکلروزیس در بیمارستان نور و الزهرای اصفهان
Background & Aim:Systemic sclerosis is a multisystem autoimmune disorder with multiple organ involvements characterized by inflammation and fibrosis involving the skin as well as internal organs. Pulmonary involvement consists of interstitial fibrosis and pulmonary vascular disease has an important effect on the course and survival of these patients. In this study, we investigated the prev...
متن کاملA Case Report of Small Cell Lung Carcinoma in a Patient with Progressive Diffuse Sclerosis
Connective tissue diseases, including scleroderma, may be associated with an increased risk of lung cancer. The most common type of lung cancer associated with systemic sclerosis is adenocarcinoma or bronchoalveolar carcinoma, and small cell carcinoma is rare. This reports presents a 54-year-old non-smoker woman with a history of scleroderma who was examined due to aggravation of shortness of ...
متن کاملThe Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease
Introduction: Pulmonary involvement is the most common cause of mortality and disability in patients with systemic sclerosis and it significantly affects the quality of life in these patients. Therefore, early diagnosis and treatment of pulmonary involvement seems necessary in patients with SSc. In this study, we aimed to assess the health-related quality of life (HRQoL) in patients with Sclero...
متن کاملStatistical analysis of clinical and laboratory characteristics of systemic sclerosis
Background: Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by vasculopathy and excessive collagen deposition in the skin and internal organs. Based on the skin damage we divide the patients into two groups: limited and diffuse SSc. In restricted type, the thickness of the skin is limited in the face and distal parts of the elbows and knees, with less involveme...
متن کاملBlocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease
Interstitial lung disease (ILD) is a commonly encountered complication of systemic sclerosis (SSc) and accounts for a significant proportion of SSc-associated morbidity and mortality. Its pathogenesis remains poorly understood, and therapies that treat SSc ILD are suboptimal, at best. SSc ILD pathogenesis may share some common mechanisms with other fibrotic lung diseases, in which dysregulation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical and experimental rheumatology
دوره 25 2 شماره
صفحات -
تاریخ انتشار 2007